AlloVir Inc (ALVR)       3.9  -0.03 (-0.76%)

3.9  -0.03 (-0.76%)

US0198181036 - Common Stock - After market: 3.9 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 32.64. This target is 736.92% above the current price.
ALVR was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALVR.
In the previous month the buy percentage consensus was at a similar level.
ALVR was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 3.9030.3032.6432.6435.70 - 676.92% 736.92% 736.92% 815.38%

Up and Down Grades

Date Firm Action Rating
2022-05-19 Piper Sandler Maintains Overweight
2022-02-10 SVB Leerink Maintains Outperform
2022-02-01 BMO Capital Initiate Outperform
2022-01-18 Morgan Stanley Maintains Overweight
2021-12-17 SVB Leerink Maintains Outperform
2021-11-08 SVB Leerink Maintains Outperform
2021-10-12 Morgan Stanley Maintains Overweight
2021-09-29 Morgan Stanley Maintains Overweight
2021-08-18 Morgan Stanley Maintains Overweight
2021-05-06 SVB Leerink Maintains Outperform
2021-04-19 Morgan Stanley Maintains Overweight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA